不同抗感染方案治疗儿童急性支气管肺炎的成本-效果分析

Different Resistance to Infection in the Treatment of Children with Acute Bronchopneumonia Cost-Effectiveness Analysis

目的分析针对儿童急性支气管肺炎的治疗应用不同抗感染方案的成本-效果。方法对我院支气管肺炎(急性)患儿进行抗感染用药回顾分析,视使用的方案分为一组(氨苄西林钠舒巴坦钠,20例)、二组(阿莫西林舒巴坦钠,22例)、三组(头孢哌酮舒巴坦钠,40例),按照药物经济学提及的方法分析各组的成本-效果。结果抗感染效果统计(以有效率为标准)一组95.0%(19/20)、二组91.0%(20/22)、三组92.5%(37/40),差异性无效;成本/效果统计一组1552.6、二组1251.8、三组1439.9。结论二组使用的为临床最佳方案。

Objective Analysis on children with acute bronchial pneumonia treatment using different anti-infectious plan cost-effect. Methods To my courtyard bronchial pneumonia （ acute ） treated with anti-infective drugs a retrospective analysis,depending on the use of the scheme as a group （ ampicillin sodium and Sulbactam Sodium for injection,20 cases ）, group two （ amoxicillin sulbactam, n=22）, group three （ cefoperazone sulbactam, n=40）, in accordance with the medicaments economics method analysis of reference groups cost- effectiveness. Results Anti-infective effect statistics （standard effective rate） of 95.0% （19/20） in a group, the two groups was 91.0% （20/22）, 92.5% （37/40） in three groups, the difference is not valid;cost / performance statistics 1552.6,1251.8,and the three groups 1439.9. Conclusion The two groups for clinical best solution.